RNS & Investor News

2024

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2023

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2022

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2021

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2020

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2019

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2018

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2017

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2016

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2015

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2014

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

 

2013

Holding(s) in Company

06 July 2018

TR-1: Standard form for notification of major holdingsi

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 Michael McGEEVER
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 3 July 2018
6. Date on which issuer notified: 3 July 2018
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BP0RTP38 2,532,142 2,532,142 3.05% 3.05%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to

 

 % of voting rights xix, xx

 
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number: